"So you say that the drug works better with Margolis 2 patients than Margolis 1 patients"
It appears so. But the company did lots of research and decided Margolis 1 data was better.
I guess we will never know. The phase 2 trial result pretty clearly indicated that our drug statistically gives no benefit (or detriment) at all.
I've let it go now and moved on. Plenty more fish etc.
